Previous Close | 9.90 |
Open | 0.00 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 92.00 |
Expire Date | 2016-04-29 |
Day's Range | 0.00 - 0.00 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
Crispr stock is down for the fifth straight week as the top Cathie Wood's holding struggles amid dim expectations for its gene-editing drug.
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $416.03, indicating a +0.09% shift from the previous trading day.
While CF remains the main area of focus for Vertex Pharmaceuticals (VRTX), it is seeing success in the development of its non-CF pipeline candidates.